PARIS and NEW YORK, July 03, 2019 (GLOBE NEWSWIRE) — Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC),  a biopharmaceutical company specializing in the development of a new drug class that directly targets the brain to treat resistant hypertension and heart […]